MarketPulse

immunotherapies

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Annexon to Present Pivotal Data Catalyst at Major Healthcare Conference

$ANNX set to showcase ARCHER II Phase 3 results targeting $1B+ geographic atrophy market at BofA Securities conference May 2026.
ANNXclinical trialbiopharmaceutical
GlobeNewswire Inc.GlobeNewswire Inc.··Na

HCW Biologics Prices $1.5M Offering; Seeks Warrant Exercise Price Reduction

HCW Biologics raised $1.5M through a unit offering and seeks shareholder approval to reduce warrant exercise price from $2.41 to $0.6055 per share.
HCWBclinical trialbiopharmaceutical